Factor-Xa inhibitors protect against systemic oxidant damage induced by peripheral-ischemia reperfusion

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 4, 2014, Pages 464-468

  Caliskan, Ahmet ^a   Yavuz, Celal ^a   Karahan, Oguz ^a   Yazici, Suleyman ^a   Guclu, Orkut ^a   Demirtas, Sinan ^a   Mavitas, Binali ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Factor Xa inhibitors; Ischemia reperfusion injury; LMWH; LMWHs; Oxidative damage; Rivaroxaban

Indexed keywords

BEMIPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; MALONALDEHYDE; NITROGEN OXIDE; PROLINE DIPEPTIDASE; RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DIPEPTIDASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RAT; REPERFUSION INJURY; THROMBOSIS; TREATMENT DURATION; ANIMAL; BLOOD; COMPLICATION; DRUG EFFECTS; SPRAGUE DAWLEY RAT;

ANIMALS; DIPEPTIDASES; FACTOR XA INHIBITORS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THROMBOSIS;

EID: 84899928188     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1019-4     Document Type: Article

References (28)

1. Yavuz C, Yazici S, Karahan O, Demirtas S, Caliskan A, Guclu O, Ertas F, Mavitas B (2013) Serum nitrogen oxide level could be a predictive biomarker for detection of critical ischaemia duration. Biomarkers 18(2):116-120
2. Hamarat M, Yenilmez A, Erkasap N, Isikli B, Aral E, Koken T, Can C, Demirustu CB (2010) Protective effects of leptin on ischemia/reperfusion injury in rat bladder. Chin J Physiol 53(3): 145-150
3. Blaisdell FW (2002) The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 10(6):620-630
4. Callum K, Bradbury A (2013) ABC of arterial and venous disease: acute limb ischaemia. BMJ 320(7237):764-767
5. Endean ED, Barnes SL, Kwolek CJ, Minion DJ, Schwarcz TH, Mentzer RM Jr (2001) Surgical management of thrombotic acute intestinal ischemia. Ann Surg 233(6):801-808 (Pubitemid 32494561)
6. Fosbol EL, Wang TY, Li S, Piccini JP, Lopes RD, Shah B, Mills RM, Klaskala W, Alexander KP, Thomas L, Roe MT, Peterson ED (2012) Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. Am Heart J 163(4):720-728
7. Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337:688-699
8. Dogan OT, Polat ZA, Karahan O, Epozturk K, Altun A, Akkurt I, Cetin A (2011) Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium. Thromb Res 128(4):e29-e32
9. Ghosh K, Ghosh K (2010) Advances in haematological pharmacotherapy in 21st century. Indian J Hematol Blood Transfus 26(2):30-40
10. Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A (2012) Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ 345:e7498
11. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351-358 (Pubitemid 9194347)
12. Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 125:193-205 (Pubitemid 12002380)
13. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N (2009) Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 15(10):RA209-RA219
14. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ (2002) Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg 26(1):115-121 (Pubitemid 36918828)
15. Yavuz C, Caliskan A, Yazici S, Karahan O, Guclu O, Demirtas S (2012) Human ischemia modified albumin can be a predictive biomarker for the detection of peripheral ischemia duration. HealthMED 6(10):3478-3481
16. O'Connell JB, Quiñones-Baldrich WJ (2009) Proper evaluation and management of acute embolic versus thrombotic limb ischemia. Semin Vasc Surg 22(1):10-16
17. Lee YK, Player MR (2011) Developments in factor Xa inhibitors for the treatment of thromboembolic disorders. Med Res Rev 31(2):202-283
18. Zhang ZG, Zhang QZ, Cheng YN, Ji SL, Du GH (2007) Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. Pharmacol Res 56(4):350-355
19. Poyrazoglu OK, Dogukan A, Yalniz M, Seckin D, Gunal AL (2006) Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients. Ren Fail 28(8):723-727 (Pubitemid 44950008)
20. Deepa PR, Varalakshmi P (2003) Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 146(2):201-210 (Pubitemid 37323883)
21. Di Pierro D, Tavazzi B, Lazzarino G, Giardina B (1992) Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart. Mol Cell Biochem 116(1-2):193-196
22. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, Marnett LJ (2003) Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278(33):31426-31433 (Pubitemid 36994664)
23. He YF, Wang YR, Li LF, Wang SH, Ye JW (2007) Effect of low molecular heparin sodium cream on the content of serum nitric oxide in random pattern skin flap: experiment with rats. Zhonghua Yi Xue Za Zhi 87(43):3092-3094 (article in Chinese)
24. Lakshmi RT, Priyanka T, Meenakshi J, Mathangi KR, Jeyaraman V, Babu M (2011) Low molecular weight heparin mediated regulation of nitric oxide synthase during burn wound healing. Ann Burns Fire Disasters 24(1):24-29
25. Karna E, Surazynski A, Palka J (2000) Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Pathol 81:341-347 (Pubitemid 32061652)
26. Furihata K, Nugent DJ, Kunicki TJ (2002) Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis. Arch Pathol Lab Med 126:305-309 (Pubitemid 34208120)
27. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y, Phang JM (2008) Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122:1435-1440 (Pubitemid 351287248)
28. Sezen Y, Bas M, Altiparmak H, Yildiz A, Buyukhatipoglu H, Faruk Dag O et al (2010) Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients. J Clin Lab Anal 24:213-218